Squarepoint
VIE

Squarepoint’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Squarepoint’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,265
Closed -$457K – 3425
2020
Q3 		$457K Buy
16,265
+7,510
+86% +$266K 0.01% 1502
2020
Q2 		$379K Buy
+8,755
New +$396K 0.01% 1462

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Squarepoint's VIE Position: Q4 2020 in Review

Squarepoint sold out of Viela Bio, Inc. Common Stock (VIE) in Q4 2020, closing a stake of 16,265 shares — an estimated $457K sold.

Squarepoint first reported a position in VIE in Q2 2020 and held it in 2 quarters. The position peaked at $457K in Q3 2020. 65 funds tracked by Wall St. Rank hold VIE as of Q4 2020.

  • Squarepoint reported no remaining Viela Bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Squarepoint sold 16,265 Viela Bio, Inc. Common Stock shares in Q4 2020, an estimated $457K.
  • Squarepoint first reported a position in Viela Bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Squarepoint's Viela Bio, Inc. Common Stock position peaked at $457K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.